These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32403068)

  • 1. The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era.
    Naser Moghadasi A
    Mult Scler Relat Disord; 2020 Jul; 42():102170. PubMed ID: 32403068
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of the multiple sclerosis community to COVID-19.
    Ciccarelli O; Cohen JA; Thompson A
    Mult Scler; 2020 Sep; 26(10):1134-1136. PubMed ID: 32924837
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?
    Brownlee WJ
    Mult Scler; 2020 Sep; 26(10):1267. PubMed ID: 32762499
    [No Abstract]   [Full Text] [Related]  

  • 4. A neurologist in the COVID unit: Reflections on a redeployment.
    Krieger SC
    Neurology; 2020 Nov; 95(19):877-880. PubMed ID: 32928972
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of multiple sclerosis under the COVID-19 pandemic.
    Holmøy T; Torkildsen Ø; Bø L
    Tidsskr Nor Laegeforen; 2020 May; 140(8):. PubMed ID: 32463200
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of COVID-19 disease in multiple sclerosis patients.
    Barzegar M; Mirmosayyeb O; Ghajarzadeh M; Nehzat N; Vaheb S; Shaygannejad V; Vosoughi R
    Mult Scler Relat Disord; 2020 Oct; 45():102276. PubMed ID: 32652473
    [No Abstract]   [Full Text] [Related]  

  • 7. An Italian programme for COVID-19 infection in multiple sclerosis.
    Sormani MP;
    Lancet Neurol; 2020 Jun; 19(6):481-482. PubMed ID: 32359409
    [No Abstract]   [Full Text] [Related]  

  • 8. Covid-19, the pandemic war: Implication for neurologists.
    de Seze J; Lebrun-Frenay C
    Rev Neurol (Paris); 2020 May; 176(4):223-224. PubMed ID: 32303331
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of COVID-19 on U.S. and Canadian neurologists' therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices.
    Mateen FJ; Rezaei S; Alakel N; Gazdag B; Kumar AR; Vogel A
    J Neurol; 2020 Dec; 267(12):3467-3475. PubMed ID: 32638107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod.
    Mallucci G; Zito A; Fabbro BD; Bergamaschi R
    Mult Scler Relat Disord; 2020 Oct; 45():102414. PubMed ID: 32711296
    [No Abstract]   [Full Text] [Related]  

  • 11. Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic.
    Naser Moghadasi A; Azadvari M; Sahraian MA
    Arch Iran Med; 2020 Jul; 23(7):509-510. PubMed ID: 32657605
    [No Abstract]   [Full Text] [Related]  

  • 12. On being a neurologist in Italy at the time of the COVID-19 outbreak.
    Bersano A; Pantoni L
    Neurology; 2020 May; 94(21):905-906. PubMed ID: 32245844
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute anosmia from COVID-19 infection.
    Mermelstein S
    Pract Neurol; 2020 Aug; 20(4):343-344. PubMed ID: 32366595
    [No Abstract]   [Full Text] [Related]  

  • 14. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.
    Suwanwongse K; Shabarek N
    Mult Scler Relat Disord; 2020 Jul; 42():102201. PubMed ID: 32480327
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19: A Review for the Pediatric Neurologist.
    Christy A
    J Child Neurol; 2020 Nov; 35(13):934-939. PubMed ID: 32660309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
    Barzegar M; Mirmosayyeb O; Nehzat N; Sarrafi R; Khorvash F; Maghzi AH; Shaygannejad V
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32371550
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series.
    Hughes R; Pedotti R; Koendgen H
    Mult Scler Relat Disord; 2020 Jul; 42():102192. PubMed ID: 32570202
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel Coronavirus: What Neuroradiologists as Citizens of the World Need to Know.
    Mahajan A; Hirsch JA
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):552-554. PubMed ID: 32198164
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple sclerosis and COVID-19.
    Mares J; Hartung HP
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain.
    Montero-Escribano P; Matías-Guiu J; Gómez-Iglesias P; Porta-Etessam J; Pytel V; Matias-Guiu JA
    Mult Scler Relat Disord; 2020 Jul; 42():102185. PubMed ID: 32408147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.